GRI Bio, Inc.

GRI · NASDAQ
Analyze with AI
7/31/2025
4/30/2025
1/31/2025
12/31/2024
Assets
Cash & Equivalents$5,122$3,281$5,028
Short-Term Investments$0$0$0
Receivables$0$0$0
Inventory$0$0$0
Other Curr. Assets$454$649$587
Total Curr. Assets$5,576$3,930$5,615
Property Plant & Equip (Net)$99$112$124
Goodwill$0$0$0
Intangibles$0$0$0
Long-Term Investments$0$0$0
Tax Assets$0$0$0
Other NC Assets$0$0$0
Total NC Assets$99$112$124
Other Assets$0$0$0
Total Assets$5,675$4,042$5,739
Liabilities
Payables$1,297$1,361$897
Short-Term Debt$104$100$96
Tax Payable$0$0$0
Deferred Revenue$0$0$0
Other Curr. Liab.$908$1,318$643
Total Curr. Liab.$2,309$2,779$1,636
LT Debt$44$58$71
Deferred Rev, NC$0$0$0
Deferred Tax Liab, NC$0$0$0
Other NC Liab.$0$0$0
Total NC Liab.$44$58$71
Other Liabilities$0$0$0
Cap. Leases$96$108$119
Total Liabilities$2,353$2,837$1,707
Equity
Pref Stock$102$0$0
Common Stock$850$0$0
Retained Earnings-$45,678-$42,786-$39,740
AOCI-$76$0$0
Other Equity$49,000$43,991$43,772
Total Equity$3,322$1,205$4,032
Supplemental Information
Minority Interest$0$0$0
Total Liab. & Tot. Equity$5,675$4,042$5,739
Net Debt-$4,974-$3,123-$4,861$0